Presspart Nemo, the injection moulding division of Presspart, has begun manufacturing a six-piece nasal drug delivery device for GlaxoSmithKline's Avamys (fluticasone furoate), an intranasal corticosteroid treatment for allergic rhinitis.
Presspart specialises in supplying metal and plastic components to the pharmaceutical industry, with Nemo developing precision plastic parts according to customer requirements.
The Avamys device is produced at the company's facilities in Spain, where it recently introduced a lean manufacturing approach to reduce waste and energy consumption while maintaining high standards of quality control.